As the takeup of these drugs, acquired via both the NHS and off-label prescriptions, continues on an ever-upward trajectory, more concerns are being raised about potential long-term side effects. A
possible link with a deterioration in bone health and skeletal muscle mass has been flagged, with Dr Doug Lucas, a trauma and orthopaedic surgeon and director of education and training for Screen My Bones, calling it potentially “catastrophic” and “frightening”. Meanwhile, a
large-scale study found that those taking GLP-1s were nearly 2.5 times more likely to develop drug-induced acute pancreatitis, a serious condition where the pancreas becomes inflamed.
Now, another warning has raised its head. Forget “
Ozempic face”, the colloquial term for ageing and sagging facial skin, deepened lines or hollowed cheeks associated with rapid weight loss – should we be worrying about the even more unpleasant-sounding “Ozempic
teeth”?